A patient with megaloblastic anemia is treated with folate alone, after which neurological symptoms worsen instead of improving. Which mechanism best explains this phenomenon?

1. A

   Folate trap

2. B

   Homocysteine accumulation

3. C

   Masking of vitamin B12 deficiency

4. D

   Pernicious anemia due to intrinsic factor deficiency

Appeared in: INI-CET EXAM -2025

Explanation

• Megaloblastic anemia can be caused by either folate or vitamin B12 deficiency, but only B12 deficiency causes neurological symptoms.
• Administering high doses of folate can correct the hematological abnormalities (anemia) of a B12 deficiency by overcoming the metabolic block in DNA synthesis.
• This 'masks' the underlying B12 deficiency, as the anemia resolves, which is a key diagnostic sign.
• However, folate cannot correct the neurological damage caused by B12 deficiency, which is related to impaired myelin synthesis.
• As the B12 deficiency remains untreated, the neurological damage progresses, leading to a worsening of symptoms despite the improvement in the blood count.

Why Other Options Were Wrong

• Option A: The 'folate trap' describes the biochemical state within cells during B12 deficiency, where folate is trapped in an unusable form, leading to anemia. It is the underlying reason for the anemia, not the explanation for why giving more folate worsens neurological signs.
• Option B: Homocysteine accumulation occurs in both vitamin B12 and folate deficiencies. It is a marker of the deficiency but does not explain the specific phenomenon of worsening neurological symptoms when only folate is replaced.
• Option D: Pernicious anemia is a specific autoimmune disease that causes vitamin B12 deficiency due to a lack of intrinsic factor. It is a potential root cause of the patient's condition, but it is not the mechanism that explains the interaction between folate therapy and neurological decline.

Related Visual

• Visual 1: Flowchart - A diagram illustrating the metabolic pathways of folate and vitamin B12. It should show how both are needed for DNA synthesis (thymidine production) but only B12 is involved in the conversion of methylmalonyl-CoA to succinyl-CoA (related to myelin health). The chart can highlight how administering excess folate can bypass the DNA synthesis block but has no effect on the myelin-related pathway.
• Visual 2: Infographic - A comparison table showing the signs and symptoms of folate vs. vitamin B12 deficiency, emphasizing the presence of neurological symptoms only in B12 deficiency and the diagnostic importance of methylmalonic acid (MMA) levels.

Clinical Relevance

• Nursing practice connection: Safe nursing care depends on performing Pathophysiology of megaloblastic anemia and the interaction between folate and vitamin B12 in the correct sequence, documenting the action clearly, and monitoring for the expected response.
• The primary clinical rule is to never treat megaloblastic anemia with folate until vitamin B12 deficiency has been excluded. This is a critical patient safety issue.
• A nurse should be vigilant for neurological signs (paresthesias, gait instability, memory changes) in any patient with anemia, especially macrocytic anemia.
• When a patient with known B12 deficiency is started on replacement therapy, the nurse should monitor for signs of hypokalemia, as the rapid production of new red blood cells can cause a sudden shift of potassium into the cells.

How to Approach the Question

• First, identify the core clinical puzzle: a treatment (folate) for a condition (megaloblastic anemia) is causing a specific set of symptoms (neurological) to worsen, not improve.
• Recall that megaloblastic anemia has two primary causes: folate deficiency and vitamin B12 deficiency.
• Consider the distinct roles of each vitamin. Both are involved in hematopoiesis (blood cell formation), but only vitamin B12 is crucial for neurological function (myelin maintenance).
• Analyze how giving folate would affect a patient with each type of deficiency. If the patient has folate deficiency, folate will cure them. If the patient has B12 deficiency, folate will fix the anemia but not the neurological problem.
• Connect these facts: by fixing the anemia, folate removes a major warning sign of the B12 deficiency, allowing the underlying neurological damage to progress unnoticed. This is known as 'masking'.
• Evaluate the options. 'Masking of vitamin B12 deficiency' directly describes this dangerous clinical phenomenon.

Concept Tested & Keywords

• Concept Tested: Pathophysiology of megaloblastic anemia and the interaction between folate and vitamin B12.
• Stem keywords: megaloblastic anemia, folate alone, neurological symptoms worsen
• Lead-in keywords: mechanism best explains

Question ID

QYSpxm7tzYI8NdrR8TX8W

Copy ID